Welcome to LookChem.com Sign In|Join Free
  • or
3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is a chemical compound with the molecular formula C16H22N2O5. It is a derivative of benzoic acid, featuring a carbamoyl group attached to the third carbon and a morpholinoethyl group attached to the methyl group. 3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is characterized by its potential pharmaceutical applications and its ability to exhibit anti-inflammatory, analgesic, and anticancer properties.

1354652-99-5

Post Buying Request

1354652-99-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1354652-99-5 Usage

Uses

Used in Pharmaceutical Research:
3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is used as a potential drug candidate for the treatment of various diseases due to its demonstrated anti-inflammatory and analgesic properties. It is particularly valuable in preclinical studies for managing pain and inflammation.
Used in Pain Management:
In the field of pain management, 3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is used as an analgesic agent to alleviate pain, providing a promising alternative for patients suffering from various types of discomfort.
Used in Anti-Inflammatory Treatments:
3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is utilized as an anti-inflammatory agent, helping to reduce inflammation and associated symptoms in various medical conditions.
Used in Anticancer Applications:
In oncology, 3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is used as an anticancer agent, showing promise in inhibiting the growth of cancer cells. Its potential in this area is currently under investigation, with ongoing research aimed at understanding its full therapeutic capabilities.
Used in Drug Development:
3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is employed in the development of new drugs, as its unique structure and properties make it a candidate for further exploration and potential incorporation into novel therapeutic agents.
Used in Medical Applications:
3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is used across various medical applications, where its multifaceted properties can be leveraged to address a range of health issues, from pain relief to cancer treatment. Further research is essential to fully realize its potential in these areas.

Check Digit Verification of cas no

The CAS Registry Mumber 1354652-99-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,4,6,5 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1354652-99:
(9*1)+(8*3)+(7*5)+(6*4)+(5*6)+(4*5)+(3*2)+(2*9)+(1*9)=175
175 % 10 = 5
So 1354652-99-5 is a valid CAS Registry Number.

1354652-99-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1354652-99-5 SDS

1354652-99-5Relevant academic research and scientific papers

Compounds and methods for inhibiting phosphate transport

-

Page/Page column 234; 235, (2016/05/02)

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein X, Y, A, R1 and R2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

-

Page/Page column 73, (2012/02/01)

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

-

Page/Page column 46-47, (2012/02/01)

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

-

Page/Page column 53, (2012/02/01)

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1354652-99-5